drugset / Trial / NCT00501878
2.5% and 10% Phenylephrine for Mydriasis in Diabetic Patients With Darkly Pigmented Irides
RandomizedParallel-groupDouble-blindDiagnostic
Summary
To compare the clinical efficacy and systemic side effects between 2.5% and 10% phenylephrine for mydriasis in diabetic patient with darkly pigmented irides.
Timeline
- Start
- 2007-05
- Primary completion
- —
- Completion
- 2007-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Phenylephrine | Small molecule | 2.5 % | Topical |
| Subject | Phenylephrine | Small molecule | 10 % | Topical |